Basic Information
Basic information for OLMALINC-229-22aa
Peptide Name OLMALINC-229-22aa
Genome Position chr10:100373776-100373841[+]
Species Human
Peptide Sequence MRRFSRLHGQPLPHNPRFFVGS
Peptide Length 22
Unique No (OLMALINC-201-22aa,OLMALINC-202-22aa,OLMALINC-203-22aa,OLMALINC-204-22aa,OLMALINC-205-22aa,OLMALINC-206-22aa,OLMALINC-207-22aa,OLMALINC-208-22aa,OLMALINC-209-22aa,OLMALINC-210-22aa,OLMALINC-211-22aa,OLMALINC-212-22aa,OLMALINC-213-22aa,OLMALINC-214-22aa,OLMALINC-215-22aa,OLMALINC-216-22aa,OLMALINC-217-22aa,OLMALINC-218-22aa,OLMALINC-219-22aa,OLMALINC-220-22aa,OLMALINC-221-22aa,OLMALINC-222-22aa,OLMALINC-223-22aa,OLMALINC-224-22aa,OLMALINC-226-22aa,OLMALINC-227-22aa,OLMALINC-228-22aa,OLMALINC-230-22aa,OLMALINC-231-22aa,OLMALINC-232-22aa,OLMALINC-234-22aa,OLMALINC-236-22aa)
Grand Average of Hydropathicity -0.75
Relative Molecular Mass 3015.37
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000235823;OLMALINC
Transcript ID/Name ENST00000666154;OLMALINC-229
Transcript Length 1070
Coding Ability 0.571
DNA Sequence Corresponding to Peptide ATGAGGCGCTTTAGCCGTCTCCACGGCCAGCCCCTCCCTCATAACCCGAGATTCTTTGTGGGCTCT
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :